CCR8 and colorectal cancer: We have recently demonstrated that an anti-CCR8 antibody armed with alpha particles emitter 225Actinium (225Ac) was able to efficiently kill CCR8+ ti-Tregs in CT26 and MC38 murine models of colorectal cancer [7].